MY ACCOUNT | NEWSLETTER |

Small-animal revolving funds: an innovative programming model to increase access to and consumption of animal-source foods by rural households in Malawi


Increased intake of animal-source foods is a key means to improve nutritional status in populations with high levels of nutrient deficiencies. However, there are few examples of programming models that have successfully improved both access to and consumption of animal products in resource-poor settings.

This chapter presents a case study of a community-based intervention to increase household access to and consumption of animal-source foods, implemented as part of a comprehensive, 9-year nutrition and health programme in Malawi. A community-managed revolving fund scheme was used to distribute small animals to rural households, accompanied by training on animal husbandry and intensive nutrition education to promote consumption of the animal products.

This was integrated into a broader anaemia control strategy, which included iron supplementation and malaria control. Cross-sectional surveys were used to evaluate programme effectiveness, including comparison of beneficiary communities with non-programme areas. Household rearing of all small animals increased from 43% to 65% in programme areas. Significantly more households in the programme area both raised and consumed the target animals at the final evaluation. Anaemia prevalence in pregnant women decreased from 59% to 48% in the programme area, but increased to 68% in the comparison group.

In pre-school children, anaemia prevalence decreased similarly in both groups. The revolving fund scheme successfully increased access to and consumption of small animals in programme communities. Anaemia prevalence decreased in women, but the specific contribution of the animals to this cannot be separated from the combined impact of the integrated programme.


Authors: A. C. MacDonald, B. J. Main, R. H. Namarika, M. E. Yiannakis, A. M. Mildon

Source: https://www.cabidigitallibrary.org/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Legacy fuels UWVC leadership in comprehensive cancer care

Like0
Dislike0

DNA My Dog Expands Product Suite With Launch of New Health and Trait Test, Building on 18-Year Foundation in Canine Genetic Testing

Like0
Dislike0

From companion animals to patients interspecies lessons in neuroendocrine oncology.

Like0
Dislike0

Clinical signs, management, and survival of 278 dogs diagnosed with insulinoma under primary veterinary care in the United Kingdom.

Like0
Dislike0

Comparative evaluation of a novel phytochemical mixture and monensin on host- and pathogen-targeted strategies in broiler chickens challenged with Eimeria maxima.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top